MYGENVIII
Live / Registered — Registered (as of 28 Feb 2023)
What this means for you
Registered since 28 Feb 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90850017
- Registration number
- 6988714
- Mark type
- Stylized text
- Filed
- 27 Jul 2021
- Published for opposition
- 13 Dec 2022
- Registered
- 28 Feb 2023
- Attorney of record
- Phillip Barengolts
Goods and services
- Class 005 — Pharmaceuticals: pharmaceutical products for the treatment of bleeding disorders; pharmaceutical products for the treatment of cardiovascular diseases; pharmaceutical products for the treatment of cancer; pharmaceutical products for the treatment of diabetes; anti-infectives; pharmaceutical products for use in cell and gene therapy for the treatment of bleeding disorders, cardiovascular diseases, cancer, diabetes, and infections
Owner
- Bayer Atkiengesellschaft, Leverkusen, DE
- Bayer Atkiengesellschaft, Leverkusen, DE
- Bayer Atkiengesellschaft, Leverkusen, DE
Prosecution history
- 17 Dec 2024 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 17 Dec 2024 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 17 Dec 2024 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 28 Feb 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 28 Feb 2023 — REGISTERED-PRINCIPAL REGISTER
- 13 Dec 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Dec 2022 — PUBLISHED FOR OPPOSITION
- 23 Nov 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 07 Nov 2022 — ELECTRONIC RECORD REVIEW COMPLETE
- 04 Nov 2022 — ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
- 31 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Oct 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 03 Oct 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 03 Oct 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 22 Apr 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED